Arizona State Retirement System Charles River Laboratories International, Inc. Transaction History

Arizona State Retirement System

  • $15.6 Billion
  • Q3 2024

A detailed history of Arizona State Retirement System transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 14,758 shares of CRL stock, worth $2.74 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,758
Previous 14,106 4.62%
Holding current value
$2.74 Million
Previous $2.91 Million 0.24%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$187.96 - $245.29 $122,549 - $159,929
652 Added 4.62%
14,758 $2.91 Million
Q2 2024

Aug 05, 2024
SELL
$206.39 - $268.73 $619 - $806
-3 Reduced 0.02%
14,106 $2.91 Million
Q1 2024

May 07, 2024
BUY
$203.52 - $273.43 $3,663 - $4,921
18 Added 0.13%
14,109 $3.82 Million
Q4 2023

Jan 24, 2024
BUY
$164.52 - $238.84 $20,894 - $30,332
127 Added 0.91%
14,091 $3.33 Million
Q3 2023

Nov 06, 2023
SELL
$194.44 - $217.61 $777 - $870
-4 Reduced 0.03%
13,964 $2.74 Million
Q2 2023

Aug 01, 2023
SELL
$183.71 - $210.25 $151,193 - $173,035
-823 Reduced 5.56%
13,968 $2.94 Million
Q1 2023

Apr 27, 2023
BUY
$191.89 - $259.92 $75,604 - $102,408
394 Added 2.74%
14,791 $2.99 Million
Q4 2022

Feb 07, 2023
BUY
$197.11 - $250.07 $88,305 - $112,031
448 Added 3.21%
14,397 $3.14 Million
Q3 2022

Nov 07, 2022
SELL
$182.44 - $250.54 $25,724 - $35,326
-141 Reduced 1.0%
13,949 $2.75 Million
Q2 2022

Jul 28, 2022
BUY
$204.13 - $302.4 $8,777 - $13,003
43 Added 0.31%
14,090 $3.02 Million
Q1 2022

May 04, 2022
BUY
$255.51 - $362.11 $83,040 - $117,685
325 Added 2.37%
14,047 $3.99 Million
Q4 2021

Feb 04, 2022
SELL
$351.38 - $448.68 $133,875 - $170,947
-381 Reduced 2.7%
13,722 $5.17 Million
Q3 2021

Nov 12, 2021
SELL
$372.64 - $458.3 $33,164 - $40,788
-89 Reduced 0.63%
14,103 $5.82 Million
Q2 2021

Aug 02, 2021
SELL
$294.17 - $371.65 $84,720 - $107,035
-288 Reduced 1.99%
14,192 $5.25 Million
Q1 2021

May 06, 2021
BUY
$249.67 - $299.48 $18,225 - $21,862
73 Added 0.51%
14,480 $4.2 Million
Q4 2020

Jan 28, 2021
SELL
$222.0 - $252.62 $116,550 - $132,625
-525 Reduced 3.52%
14,407 $3.6 Million
Q3 2020

Nov 05, 2020
BUY
$175.56 - $226.45 $660,632 - $852,131
3,763 Added 33.69%
14,932 $3.38 Million
Q2 2020

Aug 04, 2020
SELL
$118.84 - $189.72 $35,295 - $56,346
-297 Reduced 2.59%
11,169 $1.95 Million
Q1 2020

May 05, 2020
SELL
$98.9 - $178.34 $1.61 Million - $2.89 Million
-16,229 Reduced 58.6%
11,466 $1.45 Million
Q4 2019

Jan 27, 2020
SELL
$126.05 - $152.76 $343,234 - $415,965
-2,723 Reduced 8.95%
27,695 $4.23 Million
Q3 2019

Oct 31, 2019
SELL
$125.07 - $143.67 $621,222 - $713,608
-4,967 Reduced 14.04%
30,418 $4.03 Million
Q2 2019

Jul 25, 2019
BUY
$123.4 - $148.55 $93,290 - $112,303
756 Added 2.18%
35,385 $5.02 Million
Q1 2019

Apr 29, 2019
BUY
$104.82 - $146.73 $11,425 - $15,993
109 Added 0.32%
34,629 $5.03 Million
Q4 2018

Jan 28, 2019
BUY
$105.09 - $137.23 $43,612 - $56,950
415 Added 1.22%
34,520 $3.91 Million
Q3 2018

Oct 29, 2018
BUY
$112.11 - $134.54 $94,284 - $113,148
841 Added 2.53%
34,105 $4.59 Million
Q2 2018

Aug 07, 2018
BUY
$102.37 - $117.25 $120,489 - $138,003
1,177 Added 3.67%
33,264 $3.73 Million
Q1 2018

May 14, 2018
SELL
$98.19 - $115.2 $196,674 - $230,745
-2,003 Reduced 5.88%
32,087 $3.43 Million
Q4 2017

Feb 09, 2018
BUY
$100.43 - $118.09 $719,380 - $845,878
7,163 Added 26.6%
34,090 $3.73 Million
Q3 2017

Nov 14, 2017
BUY
$96.72 - $109.26 $2.6 Million - $2.94 Million
26,927
26,927 $2.91 Million

Others Institutions Holding CRL

# of Institutions
695
Shares Held
52.2M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email